Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
E2108: Systemic therapy plus early local therapy versus systemic therapy alone i...
Dr Seema Ahsan Khan - Northwestern Memorial Hospital, Chicago, USA
E2108: Systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer ( Dr Seema Ahsan Khan - Northwestern Memorial Hospital, Chicago, USA )
31 May 2020
KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy f...
Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York City, USA
KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy for extensive-stage small-cell lung cancer ( Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York City, USA )
31 May 2020
EAU guidelines for treating patients with advanced prostate cancer
Dr Eleni Efstathiou, Prof Álvaro Pinto, Prof Nicolas Mottet and Prof Heather Pay...
EAU guidelines for treating patients with advanced prostate cancer ( Dr Eleni Efstathiou, Prof Álvaro Pinto, Prof Nicolas Mottet and Prof Heather Payne )
31 May 2020
Cumulative incidence of financial hardship in metastatic colorectal cancer patie...
Dr Veena Shankaran - Fred Hutchinson Cancer Research Center, Seattle, USA
Cumulative incidence of financial hardship in metastatic colorectal cancer patients: Primary endpoint results for SWOG S1417CD ( Dr Veena Shankaran - Fred Hutchinson Cancer Research Center, Seattle, USA )
30 May 2020
Denosumab in multiple myeloma patients with renal insufficiency
Dr Elizabeth O'Donnell - Massachusetts General Hospital, Boston, USA
Denosumab in multiple myeloma patients with renal insufficiency ( Dr Elizabeth O'Donnell - Massachusetts General Hospital, Boston, USA )
30 May 2020
Association of BRCA alternations with response to PARP inhibitors in metastatic ...
Dr Emmanuel Antonarakis - John Hopkins Sidney Kimmel Comprehensive Cancer Center...
Association of BRCA alternations with response to PARP inhibitors in metastatic castration-resistant prostate cancer ( Dr Emmanuel Antonarakis - John Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )
30 May 2020
LuPSMA vs cabazitaxel in metastatic castration-resistant prostate cancer progres...
Prof Michael Hofman - Peter MacCallum Cancer Centre, Melbourne, Australia
LuPSMA vs cabazitaxel in metastatic castration-resistant prostate cancer progressing after docetaxel ( Prof Michael Hofman - Peter MacCallum Cancer Centre, Melbourne, Australia )
30 May 2020
The paediatric precision oncology study INFORM: Clinical outcome and benefit for...
Dr Cornelis van Tilburg - Hopp Children's Cancer Center Heidelberg, Heidelberg, ...
The paediatric precision oncology study INFORM: Clinical outcome and benefit for molecular subgroups ( Dr Cornelis van Tilburg - Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany )
30 May 2020
Maintenance avelumab plus best supportive care (BSC) versus BSC alone after chem...
Prof Thomas Powles - Barts Cancer Institute, London, UK
Maintenance avelumab plus best supportive care (BSC) versus BSC alone after chemotherapy in advanced urothelial carcinoma ( Prof Thomas Powles -  Barts Cancer Institute, London, UK )
29 May 2020
Brigatinib for NSCLC, latest research and overcoming complications
Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA
Brigatinib for NSCLC, latest research and overcoming complications ( Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA )
29 May 2020
Sym015 shows superior specificity compared to TKIs for NSCLC
Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA
Sym015 shows superior specificity compared to TKIs for NSCLC ( Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA )
29 May 2020
CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell th...
Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy for r/r multiple myeloma ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
29 May 2020